SAM
FENC icon

Smartleaf Asset Management’s Fennec Pharmaceuticals FENC Stock Holding History

Smartleaf Asset Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21K Hold
110
– – ﹤0.01% 3067
2026
Q1 		$635 Hold
110
– – ﹤0.01% 3186
2025
Q4 		$854 Hold
110
– – ﹤0.01% 3182
2025
Q3 		$999 Hold
110
– – ﹤0.01% 2750
2025
Q2 		$907 Hold
110
– – ﹤0.01% 2493
2025
Q1 		$715 Hold
110
– – ﹤0.01% 2639
2024
Q4 		$677 Buy
+110
New +$563 ﹤0.01% 2736

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Smartleaf Asset Management's FENC Position: Q2 2026 in Review

Smartleaf Asset Management held its Fennec Pharmaceuticals (FENC) position steady in Q2 2026 at 110 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #3067.

Smartleaf Asset Management first reported a position in FENC in Q4 2024 and has held it in 7 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Smartleaf Asset Management held 110 shares of Fennec Pharmaceuticals worth $1.21K as of Q2 2026.
  • Smartleaf Asset Management left its Fennec Pharmaceuticals share count unchanged in Q2 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #3067 holding.
  • Smartleaf Asset Management first reported a position in Fennec Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.